{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:31:22Z","timestamp":1775766682502,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recently, the expression of the mast cell (MC) receptor Mas-related G protein\u2013coupled receptor X2 (MRGPRX2) has been detected in lesional skin of adult patients with cutaneous mastocytosis. As of yet, little is known about the clinical relevance of MRGPRX2 and its agonists in patients with mastocytosis, including indolent systemic mastocytosis (ISM).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MRGPRX2 and MRGPRX2 agonists, cortistatin (CST), and major basic protein (MBP) were analyzed in lesional and non-lesional skin of patients with ISM and skin of healthy controls by immunohistochemistry. Co-localization of MRGPRX2 and MRGPRX2-mRNA with the MC marker tryptase was assessed by immunofluorescence microscopy and <jats:italic>in situ<\/jats:italic> hybridization, respectively. We assessed clinical, demographic, and laboratory data, including mastocytosis activity score (MAS), serum tryptase, and <jats:italic>KIT<\/jats:italic> D816V allele burden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The number of MRGPRX2-expressing (MRGPRX2+) cells, MRGPRX2-mRNA+ MCs, and CST-expressing (CST+) and MBP-expressing (MBP+) cells was significantly higher in lesional skin as compared to non-lesional skin and\/or skin of healthy controls (all p &amp;lt; 0.05). Increased numbers of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells were not associated with clinical and laboratory features of ISM, including disease burden, symptom severity, evidence of anaphylaxis, and tryptase levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Skin lesions of patients with ISM showed high numbers of MRGPRX2+ cells, although they were not linked to symptom severity. Clinical relevance of the MRGPRX2-mediated pathway of MC activation in ISM remains unclear and should be investigated in further studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.930945","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T12:45:16Z","timestamp":1658839516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity"],"prefix":"10.3389","volume":"13","author":[{"given":"Polina","family":"Pyatilova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tameem","family":"Ashry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Bonnekoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherezade","family":"Mo\u00f1ino-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Frischbutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud A. W.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford A.","family":"Youngblood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of Systemic Mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246380","article-title":"A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network","volume":"13","author":"Zanotti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of Indolent Systemic Mastocytosis in a Dutch Region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.14676","article-title":"Everyday Life and Mastocytosis From a Patient Perspective-a Qualitative Study","volume":"28","author":"Jensen","year":"2019","journal-title":"J Clin Nurs"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 Updated WHO Classification and Novel Emerging Treatment Concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/all.13425","article-title":"Development and Validation of the Mastocytosis Activity Score","volume":"73","author":"Siebenhaar","year":"2018","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous Manifestations in Patients With Mastocytosis: Consensus Report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/all.12842","article-title":"Development and Validation of the Mastocytosis Quality of Life Questionnaire: MC-QoL","volume":"71","author":"Siebenhaar","year":"2016","journal-title":"Allergy"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00110","article-title":"Targeted Treatment Options in Mastocytosis","volume":"4","author":"Vaes","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding Human Mast Cells: Lesson From Therapies for Allergic and Non-Allergic Diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11882-015-0582-5","article-title":"Hymenoptera Allergy and Mast Cell Activation Syndromes","volume":"16","author":"Bonadonna","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.015","article-title":"Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis","volume":"7","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in Skin Mast Cells of Patients With Maculopapular Cutaneous Mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature14022","article-title":"Identification of a Mast-Cell-Specific Receptor Crucial for Pseudo-Allergic Drug Reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-Related Gene X2 on Mast Cells is Upregulated in the Skin of Patients With Severe Chronic Urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302456200","article-title":"MrgX2 Is a High Potency Cortistatin Receptor Expressed in Dorsal Root Ganglion","volume":"278","author":"Robas","year":"2003","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100719","DOI":"10.1016\/j.bbrep.2019.100719","article-title":"Peptides of Major Basic Protein and Eosinophil Cationic Protein Activate Human Mast Cells","volume":"21","author":"Ogasawara","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-Related G Protein-Coupled Receptor X2 and its Activators in Dermatologic Allergies","volume":"147","author":"Kuhn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.277152","article-title":"Mas-Related Gene X2 (MrgX2) Is a Novel G Protein-Coupled Receptor for the Antimicrobial Peptide LL-37 in Human Mast Cells: Resistance to Receptor Phosphorylation, Desensitization, and Internalization","volume":"286","author":"Subramanian","year":"2011","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav0216","article-title":"MRGPR-Mediated Activation of Local Mast Cells Clears Cutaneous Bacterial Infection and Protects Against Reinfection","volume":"5","author":"Arifuzzaman","year":"2019","journal-title":"Sci Adv"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.01.059","article-title":"Anaphylaxis to Quinolones in Mastocytosis: Hypothesis on the Mechanism","volume":"7","author":"Giavina-Bianchi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835618","article-title":"Overexpression of FcepsilonRI on Bone Marrow Mast Cells, But Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis","volume":"13","author":"Elst","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.02.021","article-title":"Mast Cells, Cortistatin, and its Receptor, MRGPRX2, Are Linked to the Pathogenesis of Chronic Prurigo","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2012.01.007","article-title":"Mast Cells and Eosinophils in Mastocytosis, Chronic Eosinophilic Leukemia, and non-Clonal Disorders","volume":"49","author":"Gotlib","year":"2012","journal-title":"Semin Hematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2018.04.006","article-title":"Darier's Sign in Urticaria Pigmentosa-Significance of Perivascular Eosinophilic Infiltration","volume":"67","author":"Maehara","year":"2018","journal-title":"Allergol Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/all.14213","article-title":"The Pseudoallergen Receptor MRGPRX2 on Peripheral Blood Basophils and Eosinophils: Expression and Function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13682","article-title":"The Neuropeptide Cortistatin Attenuates Experimental Autoimmune Myocarditis via Inhibition of Cardiomyogenic T Cell-Driven Inflammatory Responses","volume":"174","author":"Delgado-Maroto","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12836","article-title":"Cortistatin is Dysregulated in Skin Tissue of Patients With Psoriasis Vulgaris and Suppresses Keratinocyte Proliferation In Vitro","volume":"54","author":"Li","year":"2015","journal-title":"Int J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/all.15270","article-title":"FcepsilonRI- and MRGPRX2-Evoked Acute Degranulation Responses are Fully Additive in Human Skin Mast Cells","volume":"77","author":"Babina","year":"2022","journal-title":"Allergy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jaci.2021.07.027","article-title":"A Novel Approach for Studying Mast Cell-Driven Disorders: Mast Cells Derived From Induced Pluripotent Stem Cells","volume":"149","author":"Luo","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.930945\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T12:45:20Z","timestamp":1658839520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.930945\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2022.930945"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.930945","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"930945"}}